Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada

Abstract

Objectives To examine whether the case fatality rate (CFR) of coronavirus disease 2019 (Covid-19) decreased overtime, and whether the Covid-19 testing rate is a driving factor for the changes if the CFR decreased. Methods Analyzing Covid-19 cases, deaths, and tests in Ontario, Canada, we compared the CFR between the first wave and the second wave across 26 Public Health Units in Ontario. We also explored whether a high testing rate was associated with a large CFR decrease. Results The first wave CFR ranged from 0.004 to 0.146; whereas the second wave CFR ranged from 0.003 to 0.034. The pooled RR estimate of the second wave Covid-19 case fatality, compared to first wave, was 0.24 (95% CI: 0.19-0.32). Additionally, Covid-19 testing percentages were not associated with the estimated RR (p-value = 0.246). Conclusions The Covid-19 CFR decreased profoundly in Ontario during the second wave, and Covid-19 testing was not a driving factor for this decrease.

COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement Therapy

“…General population data from several countries suggested a lower risk of mortality in the second wave compared to the first wave. 1) , 2) , 3) Some of the potential explanations for this included the increased identification of young individuals with COVID-19 1 , improved test capacity leading to the identification of less severe cases, 2 and improved patient management 3 during the second wave compared with the first wave.…”

Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning

“…3 ). While trends of decreasing severity are consistent with improved patient outcomes due to vaccination and improved therapeutics [81] , [82] , [83] , [84] , [85] , [86] , they may also reflect changes in sequence collection practices, such as obtaining more sequences and performing more studies based on screening the general public outside of hospital settings. These artifacts can have significant impacts on modeling studies.…”

“…The declining severity trend through 2020 in GISAID data is consistent with a period of improved COVID-19 therapeutics. For example, a Canadian study measured a decrease in case fatality rate (CFR) between the first and second waves prior to any vaccination, even when controlling for age and increased testing [81] . Later reduction is consistent with increased levels of COVID-19 vaccination reducing severe outcomes [82] , [83] , [84] , [85] , as well as continued improvements in therapeutics such as monoclonal antibodies [86] .…”

An Interpretable Deep Learning Model for Predicting the Risk of Severe COVID-19 from Spike Protein Sequence

“…For example, the early decline in 2020 in average case severity is consistent with a Canadian study showing that the case fatality rate (CFR) decreased between the first and second waves prior to any vaccination, even when controlling for age and increased testing. 40 The latter decline may be accounted for by better understanding of how to treat COVID-19, and, later in 2020, the emergence of monoclonal antibody therapies. The accelerated decline in case severity starting in early 2021 coincides with increasing vaccination rates, particularly of older and more vulnerable people.…”